David P. Elder has thirty four years experience within the Pharmaceutical Industry. He is currently a director at GlaxoSmithKline Pharmaceuticals.
He obtained a part-time PhD from Edinburgh University in1992 investigating the crystal structure and solid-state chemistry of a series of pharmaceutical salts.
He is a member of the BP-Committee PCY: Pharmacy. He is a fellow of the Royal Society of Chemistry (FRSC), a Chartered Chemist, Chartered Scientist and is eligible to be a Qualified Person. He is a member of the EfPIA, PhRMA and PQRI sub-groups on genotoxic impurities. He is a committee member of Joint Pharmaceutical Analysis Group, a member of the Council of Analytical Division, RSC and an ex officio trustee of the Analytical Chemistry Trust Fund.
He has authored 47 papers and has written 7 chapters in several Pharmaceutical textbooks. He has presented several webinars and 55 seminars at various UK, European and US scientific meetings.
Share this
Appearances at this years' conference:
Wednesday 23 May 2012- Accelerating early development stream
@ 11.15
Challenges in formulation development in first-in-human strategies
Attrition overview
Importance of solubility/permeability in absorption (BCS approach)